Viral Hepatitis C Clinical Trial
Official title:
Reducing the Risk of Viral Hepatitis C and Other Sexually Transmitted Infections Among People Living With HIV Who Are Men Who Have Sex With Men: Efficacy of Serious Game Interventions
The study is aimed to provide high-risk, HIV-infection, men who have sex with men (MSM) with healthcare education regarding viral hepatitis C, through either serious game intervention or traditional online health education. After the education, each participants will be followed for 48 weeks and the change of risky sexual behaviors, acquisition of HCV and other STIs will be followed during the study periods.
High-risk MSM living with HIV were participated in our study will be assigned (by randomization) to either: 1. Serious game intervention: 1 single session of serious game for the participants to play (estimation to take 25-40 minutes). Hepatitis C virus (HCV)-related healthcare informations, including the severity of illness, route of transmission, preventive strategies and treatment options, would be embedded in the game. 2. Traditional online health education (reading materials): 1 single session of healthcare education regarding HCV (with similar contents) will be provided. After the healthcare intervention, each participants will be followed for 48 weeks. Assessment of risky sexual practice (by questionnaire), test of plasma HCV RNA and serological test of syphilis (optional), and detection of sexually-transmitted bacterial pathogens (optional) will be performed at the enrollment and then every 12 weeks during the observation. ;
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Not yet recruiting |
NCT04470271 -
Re-linkage to Care of Patients With Hepatitis C
|
||
| Completed |
NCT03537196 -
DRug Use & Infections in ViEtnam - Hepatitis C (DRIVE-C)
|
Phase 4 | |
| Completed |
NCT03566966 -
Autoantibodies and Direct-acting Antivirals
|
||
| Completed |
NCT04047680 -
eGFR Evolution in HCV Patients Receiving SOF-based or SOF-free DAAs
|
||
| Not yet recruiting |
NCT04690972 -
"Constitution of a Biological Collection to Establish Preclinical Translational Models for the Study of Tumors and Chronic Liver Diseases".
|
||
| Active, not recruiting |
NCT01953458 -
Therapeutic Option for Hepatitis B and C: a French Cohort
|
||
| Completed |
NCT02125500 -
Pilot Study to Assess Efficacy and Safety of Sofosbuvir/Ledipasvir Fixed-dose Combination in Treatment Experienced Subjects With Hepatitis C Virus (HCV) Genotype 1 - HIV Co-infection
|
Phase 2 | |
| Withdrawn |
NCT01766115 -
Hepatitis C Virus Post-Exposure Prophylaxis for Health Care Workers
|
Phase 4 |